Company Filing History:
Years Active: 2010-2015
Title: Innovations of Emily Stauffer in Pharmaceutical Research
Introduction
Emily Stauffer is a prominent inventor based in San Francisco, CA. She has made significant contributions to the field of pharmaceutical research, particularly in the development of compounds that inhibit protein kinase C (PKC). With a total of three patents to her name, Stauffer's work is paving the way for new treatments for various diseases and disorders.
Latest Patents
Stauffer's latest patents focus on protein kinase C inhibitors and their uses. These disclosures detail compounds that serve as effective inhibitors of PKC, which is crucial for treating a range of diseases and disorders mediated by PKC activity. The patents also cover pharmaceutical compositions that include these compounds, methods for their application in treating various conditions, and processes for preparing these compounds and their intermediates.
Career Highlights
Emily Stauffer is currently associated with Rigel Pharmaceuticals, Incorporated, where she continues to innovate in the pharmaceutical sector. Her work is instrumental in advancing therapeutic options for patients suffering from diseases linked to PKC.
Collaborations
Stauffer collaborates with notable colleagues, including Rajinder Paul Singh and Rao Kolluri, enhancing the research and development efforts at her company.
Conclusion
Emily Stauffer's contributions to pharmaceutical research, particularly through her patents on protein kinase C inhibitors, highlight her role as a leading inventor in the field. Her work not only showcases her innovative spirit but also promises to impact the treatment landscape for various diseases.